In the past decades the management of acute coronary syndromes (ACS), including myocardial infarction (MI) and unstable angina, has evolved from a strategy of watchful waiting to a highly technical intervention with anti-blood clotting drugs and percutaneous coronary intervention (PCI) with stent placement. As a result, the prognosis of patients has improved radically. In the 1960s in-hospital mortality in MI patients was as high as 30%. After the widespread introduction of coronary care units (CCU) in the 1970s this figure was reduced to approximately 15%, figure 1. Further improvements were made with the introduction of fibrinolytic drugs (1980s) and PCIs (1990s). Currently, 30 day mortality after MI admission has been reduced to 4 - 6 %.

Additional Metadata
Keywords coronary diesease, glucose
Promotor H. Boersma (Eric)
Publisher Erasmus University Rotterdam
Sponsor Het verschijnen van dit proefschrift werd mede mogelijk gemaakt door de steun van de Nederlandse Hartstichting.
ISBN 978-90-70116-40-8
Persistent URL
de Mulder, M. (2013, October 15). Glucose Regulation in Acute Coronary Syndromes: Implications for outcome and outcome prediction. Erasmus University Rotterdam. Retrieved from